<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352868</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300004596</org_study_id>
    <nct_id>NCT04352868</nct_id>
  </id_info>
  <brief_title>Customizing Myopia Control With Multifocal Toric Contact Lens</brief_title>
  <official_title>Customizing Myopia Control With Multifocal Toric Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the ability of toric multifocal contact lens to reduce the change of
      myopia progression in children (aged 8-12) with myopic astigmatism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess if a center distance toric multifocal contact lenses
      can slow the amount of change of myopia progression in children with myopia plus astigmatism.
      Multifocal contact lenses have been theorized to influence the peripheral optics of the eye
      such that they slow the rate of myopia progression in nearsighted children. This outcome is
      yet to be evaluated in children with myopia plus astigmatism.The secondary outcome is to
      measure the change in peripheral optics caused by the contact lens. This information is key
      to understanding the mechanism of multifocal contact lens optics on the eye. Ultimately this
      information would be used to create a software that can estimate the effect of multifocal
      contact lenses on the peripheral optics of the child's eye. This software can potentially be
      used by practitioners worldwide to better customize multifocal contact lenses to slow myopia
      progression.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Refractive error progression</measure>
    <time_frame>1 years</time_frame>
    <description>Refractive error measured by cycloplegic autorefraction in both eyes, will be measured at baseline and at one year to assess the difference in spherical component of the refractive error between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial length</measure>
    <time_frame>1 years</time_frame>
    <description>Change in axial length as measured by non-contact axial length both eyes, will be measured at baseline and at one year to assess the difference in change in axial length between the treatment group (multifocal toric soft contact lens) and the control group (toric soft contact lens)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Refractive Errors</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Toric soft contact lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Toric soft contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multifocal toric soft contact lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A multifocal toric soft contact lens with a +2.00 D add.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intelliwave multifocal, toric, soft contact lens</intervention_name>
    <description>This is a quarterly disposable, multifocal, toric soft contact lens commercially available from Art Optical Contact Lens, Inc.</description>
    <arm_group_label>Multifocal toric soft contact lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intelliwave toric, soft contact lens</intervention_name>
    <description>This is a quarterly disposable toric soft contact lens commercially available from Art Optical Contact Lens, Inc.</description>
    <arm_group_label>Toric soft contact lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  8 to 12 years, inclusive, at baseline examination

          -  -0.50 to -6.00 D, inclusive, spherical component, cycloplegic autorefraction

          -  â‰¥0.75 DC, cycloplegic autorefraction

          -  0.1 logMAR or better best-corrected visual acuity in each eye

        Exclusion Criteria:

          -  Eye disease or refractive error conditions (e.g., keratoconus, retinal abnormalities,
             retinopathy of prematurity, etc.)

          -  Ocular surgery, severe ocular trauma, active ocular infection or inflammation

          -  Subjects with a condition or in a situation, which in the examiner's opinion, may put
             the subject at significant risk, may confound the study results, or may significantly
             interfere with their participation in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew D Pucker, OD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew D Pucker, OD, PhD</last_name>
    <phone>205.975.9938</phone>
    <email>apucker@uab.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew D Pucker, OD, PhD</last_name>
      <phone>205-975-9938</phone>
      <email>apucker@uab.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Andrew Pucker</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>Multifocal contact lens</keyword>
  <keyword>Refractive error</keyword>
  <keyword>Myopia treatment</keyword>
  <keyword>Myopia control</keyword>
  <keyword>Myopia management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual subject data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

